<i>IL1RL1</i> asthma risk variants regulate airway type 2 inflammation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 27699235.
- Also identified by DOI 10.1172/jci.insight.87871 and PMC identifier 5033813.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Genome-wide association studies of asthma have identified genetic variants in the <i>IL1RL1</i> gene, but the molecular mechanisms conferring risk are unknown. <i>IL1RL1</i> encodes the ST2 receptor (ST2L) for IL-33 and an inhibitory decoy receptor (sST2). IL-33 promotes type 2 inflammation, which is present in some but not all asthmatics. We find that two single nucleotide polymorphisms (SNPs) in <i>IL1RL1</i> - rs1420101 and rs11685480 - are strongly associated with plasma sST2 levels, though neither is an expression quantitative trait locus (eQTL) in whole blood. Rather, rs1420101 and rs11685480 mark eQTLs in airway epithelial cells and distal lung parenchyma, respectively. We find that the genetically determined plasma sST2 reservoir, derived from the lung, neutralizes IL-33 activity, and these eQTL SNPs additively increase the risk of airway type 2 inflammation among asthmatics. These risk variants define a population of asthmatics at risk of IL-33-driven type 2 inflammation.
Medical subject headings
- Asthma
- Interleukin-1 Receptor-Like 1 Protein
- Quantitative Trait Loci